A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria
Public ClinicalTrials.gov record NCT05967806. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An International, Non-randomised, Non-interventional, Multicentre Study to Identify and Characterise Patients With CKD and High Proteinuria for Possible Participation in Future Renal Clinical Studies.
Study identification
- NCT ID
- NCT05967806
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 2,575 participants
Conditions and interventions
Conditions
Interventions
- assessment Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2023
- Primary completion
- Aug 29, 2024
- Completion
- Aug 29, 2024
- Last update posted
- Apr 5, 2025
2023 – 2024
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35805 | — |
| Research Site | Bakersfield | California | 93309 | — |
| Research Site | Chatsworth | California | 91311 | — |
| Research Site | San Carlos | California | 94070 | — |
| Research Site | South Gate | California | 90280 | — |
| Research Site | Tarzana | California | 91356 | — |
| Research Site | Victorville | California | 92395 | — |
| Research Site | Jacksonville | Florida | 28546 | — |
| Research Site | Miami | Florida | 33165 | — |
| Research Site | Kinston | North Carolina | 28504 | — |
| Research Site | New Bern | North Carolina | 28562 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Greenville | South Carolina | 27834 | — |
| Research Site | Pearland | Texas | 77584 | — |
| Research Site | San Antonio | Texas | 78204 | — |
| Research Site | Arlington | Virginia | 76015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05967806, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2025 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05967806 live on ClinicalTrials.gov.